Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/10/15  and contains information from public web pages.

Nicolas Pineault

Wrong Nicolas Pineault?


Phone: (613) ***-****  HQ Phone
Canadian Blood Services
1800 Alta Vista Drive
Ottawa , Ontario K1G 4J5

Company Description: Canadian Blood Services is a national, not-for-profit charitable organization that manages the blood supply in all provinces and territories outside of Quebec and...   more

Employment History


  • PhD
19 Total References
Web References
Canadian Blood Services - Société canadienne du sang - F_R&DbioPineault [cached]
Biographie - Nicolas Pineault
PINEAULT, N., V. CORTIN, L. BOYER, A. GARNIER, A. ROBERT, C. THERIEN et D.-C. ROY. « Individual and synergistic cytokine effects controlling the expansion of cord blood CD34+ cells and megakaryocyte progenitors in culture », Cytotherapy, 2011, vol. 11, no 4, p. 467-480.
Canadian Blood Services - Société canadienne du sang - R&DbioPineault [cached]
Biography - Nicolas Pineault
Scientist, Canadian Blood Services
Canadian Blood Services - Société canadienne du sang - R&DbioPineault [cached]
Biography - Nicolas Pineault
Scientist, Canadian Blood Services
Award Recipients: Kent Christopherson II, ... [cached]
Award Recipients: Kent Christopherson II, PhD; Cheryl Lobo, PhD; Nicolas Pineault, PhD
Seven Individuals Receive Scientific Research Grants from The National Blood Foundation [cached]
This year's recipients are: Alicia Bárcena, PhD; Daniel Gonzalez-Nieto, PhD; Taku Kambayashi, MD, PhD;Chance John Luckey, MD, PhD; Nicolas Pineault, PhD; Ayaz Rahman, MD; and Rahima Zennadi, PhD.
Nicolas Pineault, PhD, Héma-Québec
A cellular-based therapy to prevent or reduce thrombocytopenia.
Thrombocytopenia, a dangerous condition in which there are not enough platelets in the blood, can result from several diseases as well as high-dose chemotherapy and stem cell transplantation. Platelet transfusion is currently the only treatment available; however, patients undergoing multiple transfusions are at greater risk of developing an immune response to the donor platelets. Pineault and his research team are aiming to establish a cellular-based therapy that will hasten platelet recovery in patients, which would translate into a faster return to health.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.